Keybank National Association Alkermes Plc. Transaction History

Keybank National Association

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 08, 2018	SELL	$47.69 - $55.39 $256,715 - $298,164	-5,383 Closed	0 $0
Q3 2017 Nov 02, 2017	SELL	$49.16 - $54.45 $15,583 - $17,260	-317 Reduced 5.56%	5,383 $274,000
Q2 2017 May 14, 2018	SELL	N/A	-6,032 Reduced 51.41%	5,700 $330,000
Q1 2017 May 14, 2018	SELL	N/A	-621 Reduced 5.03%	11,732 $686,000
Q4 2016 May 14, 2018	BUY	N/A	12,353	12,353 $687,000

361

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.73B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

Stay updated on Keybank National Association with notifications on news.